- Filed
- Jun 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Jun 9, 2026 | 13.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 13.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 12.54M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $315.39K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $102.12K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $57.11K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.06M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $956.72K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$35.62M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$34.75M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$28.12M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$27.36M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $38.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $36.82M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $40.63M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $39.23M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.57M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.22M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.01M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.49M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$876.27K |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$760.04K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $229.78K |
| Operating Income | Q1 2026 · Mar 31, 2025 | $134.96K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.77M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $943.89K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $872.86K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $420.45K |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.64M |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.36M |